The review committee shall consist of: (a) one physician licensed to practice medicine in this state and certified by the American Board of Ophthalmology; (b) one physician licensed to practice medicine in this state, certified by the American Board of Internal Medicine and also certified in the subspecialty of medical oncology; (c) one physician licensed to practice medicine in this state, certified in the specialty of pediatrics and also certified in the subspecialty of pediatrics oncology; (d) one physician licensed to practice medicine in this state, certified in the specialty of gynecology and also certified in the subspecialty of gynecological oncology; (e) one physician licensed to practice medicine in this state, certified in the specialty of radiology and also certified in the subspecialty of radiation oncology; and (f) the director of the Comprehensive Cancer Center of the University of Alabama in Birmingham.
Structure Code of Alabama
Title 20 - Food, Drugs and Cosmetics.
Chapter 2 - Controlled Substances.
Article 6 - Therapeutic Research.
Section 20-2-110 - Short Title.
Section 20-2-111 - Legislative Findings; Cannabis Research.
Section 20-2-112 - Definitions.
Section 20-2-115 - Composition of Review Committee.
Section 20-2-118 - Annual Reports to Governor and Legislature.
Section 20-2-119 - Enumeration as Schedule I or Ii Substance Inapplicable.